TSMHT
CNMD icon

Thurston Springer Miller Herd & Titak’s CONMED CNMD Stock Holding History

Thurston Springer Miller Herd & Titak’s Portfolio CNMD Stock Details CNMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-3
Closed -$181 – 1652
2025
Q1 		$181 Buy
+3
New +$193 ﹤0.01% 1640

Other funds holding CNMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
WHG
Westwood Holdings Group Dallas, Texas $13.7B AUM 21.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Thurston Springer Miller Herd & Titak's CNMD Position: Q2 2025 in Review

Thurston Springer Miller Herd & Titak sold out of CONMED (CNMD) in Q2 2025, closing a stake of 3 shares — an estimated $181 sold.

Thurston Springer Miller Herd & Titak first reported a position in CNMD in Q1 2025 and held it in 1 quarter. The position peaked at $181 in Q1 2025. 276 funds tracked by Wall St. Rank hold CNMD as of Q2 2025.

  • Thurston Springer Miller Herd & Titak reported no remaining CONMED position as of Q2 2025 after selling out during the quarter.
  • Thurston Springer Miller Herd & Titak sold 3 CONMED shares in Q2 2025, an estimated $181.
  • Thurston Springer Miller Herd & Titak first reported a position in CONMED in Q1 2025 and held it in 1 quarter.
  • Thurston Springer Miller Herd & Titak's CONMED position peaked at $181 in Q1 2025.
  • 276 funds tracked by Wall St. Rank held CONMED as of Q2 2025.

Based on Thurston Springer Miller Herd & Titak's 13F filing for Q2 2025, filed 7 Jul 2025.